SLC5A8 · Western blot design guide

Design a Western Blot for SLC5A8

Real validated SLC5A8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SLC5A8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Last reviewed: May 2026 · Scientific review: Boster Bio technical team
Western blot protocol sheet for SLC5A8: expected band ~66.6 kDa, antibody A03883-3, and PMC-cited SDS-PAGE protocol steps
SLC5A8 Western blot protocol sheet — expected band ~66.6 kDa, antibody A03883-3, controls and PMC citations. Open the full SLC5A8 WB guide →

SLC5A8 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~66.6 kDa
Observed band Approximately 67 kDa
Gel 10–12%
Negative control ⓘ siRNA / KO lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated
Caveat Glycosylation-based mobility shift
Regulation LPS-induced
Isoform 1 isoform(s)
Section 1

Real Curated SLC5A8 Western Blot Protocols

Literature-validated Western blot parameters for SLC5A8 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.

Recommended Western blot protocol parameters
Sample / lysatemouse kidney . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-SLC5A8 antigen affinity purified polyclonal antibody (Catalog # A03883-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for SLC5A8 at approximately 67 kDa. The expected band size for SLC5A8 is at 67 kDa
Gel %10–12%
Load30 ug
Transfernitrocellulose membrane, 150 mA, 50–90 min
Membranenitrocellulose
Blocking5% non-fat milk / TBS, 1.5 h RT
Primary antibody0.5 µg/mL
Primary incubationovernight at 4 °C
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000
WashTBS-0.1% Tween, 3 × 5 min
DetectionECL
Exposure / imagingTanon 5200
Observed band67 kDa
Section 2

What Is the Expected SLC5A8 Western Blot Band Size?

SLC5A8 has a 66.6 kDa predicted backbone but runs at approximately 67 kDa, a small shift attributable to its single N-glycosylation site at Asn485.

What am I looking at on my blot?
single band at approximately 67 kDamatches the predicted 66.6 kDa monomeric mass of full-length SLC5A8, with only a modest upward shift
band running slightly above the 66.6 kDa predicted massreflects the added mass from the single N-linked glycan at Asn485
no additional lower-molecular-weight cleavage productSLC5A8 has no annotated signal peptide or propeptide, so the full-length precursor is itself the mature membrane-embedded form
no additional bands from alternate transcriptsonly one isoform is annotated for SLC5A8, so a single band is expected rather than a multi-band ladder
band present or absent depending on tissue sourceSLC5A8 is restricted to the apical membrane of specific epithelial cells (kidney, colon, thyroid), so signal is tissue-dependent rather than a technical failure
no shift to roughly double the monomer mass under non-reducing conditionsno disulfide bonds are annotated, so no covalent homodimer band is expected regardless of reduction
💡Expected SLC5A8 appearanceExpect a single band at approximately 67 kDa, closely matching the 66.6 kDa predicted mass of full-length SLC5A8, with only a modest upward shift from the single N-glycosylation site at Asn485.
How each factor affects band size
Predicted mass (66.6 kDa, 610 aa)sets the baseline unmodified migration position for the full-length monomer
N-glycosylation at Asn485adds modest mass, shifting the native band slightly above 66.6 kDa toward the observed ~67 kDa
Absence of signal peptide or propeptideno precursor-to-mature cleavage occurs, so no separate smaller processed band is expected
Absence of annotated disulfide bondsno covalent homodimer forms, so reducing versus non-reducing conditions should not change the apparent band size
Single annotated isoformno isoform-driven secondary bands are expected; extra bands point to degradation or nonspecific binding rather than splice variation
Multi-pass apical membrane proteinincomplete solubilization or aggregation of this membrane protein can cause smearing or higher-apparent-mass species on standard SDS-PAGE
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateSLC5A8 expression is restricted to the apical membrane of kidney, colon, and thyroid epithelia and is absent from non-expressing tissues or cell linesconfirm the sample is from a tissue known to express SLC5A8 and include a validated positive-control lysate
Band higher than expectedincomplete solubilization or aggregation of this multi-pass membrane protein, compounded by its N-linked glycanuse a membrane-optimized lysis buffer with adequate detergent and avoid boiling the sample at high temperature before loading
Broad smear instead of sharp bandheterogeneous glycosylation at the single N-linked site combined with membrane protein aggregationtreat a parallel sample with PNGase F to sharpen the band and optimize gel percentage and transfer conditions for membrane proteins
Multiple bandsonly one isoform is annotated, so additional bands more likely reflect nonspecific antibody binding or degradation than splice variantsvalidate antibody specificity with a knockdown or knockout control and add fresh protease inhibitors during lysis
Weak or no signallow native abundance outside apical-membrane-expressing tissues, or inefficient transfer of a large hydrophobic multi-pass membrane proteinload more total protein, extend transfer time for large membrane proteins, and confirm use of an expressing tissue
Fragments below expected sizeproteolytic degradation during lysis, since no propeptide or signal-peptide cleavage is annotated for this proteinkeep samples cold throughout preparation and use fresh protease-inhibitor-supplemented lysis buffer

Sample controls for SLC5A8 Western blot

🧪For positive controls for SLC5A8 in Western blot, you can use normal colon tissue lysate, where SLC5A8 is expressed at the apical membrane of colonic epithelial cells.
Positive control: Colon tissue (colonic epithelial cells)
Negative control: No HPA expression data available; use siRNA knockdown or KO line
Loading controls: Run GAPDH and β-actin blots alongside a total-protein stain (e.g., stain-free gel, Ponceau S, or REVERT) as loading controls.
⚠️Feasibility: HPA provides no expression data and SLC5A8 is restricted to the apical membrane of thyroid and colonic epithelial cells, so no confirmed negative tissue is available and siRNA knockdown or a KO line is needed to validate specificity.

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Section 3

Advanced SLC5A8 Western Blot Tips

Deeper troubleshooting and optimisation questions for SLC5A8, answered from its protein features.

Why does SLC5A8 run close to its predicted mass?
With no phosphorylation or disulfide-linked processing annotated and only a single N-glycosylation site, SLC5A8 shows minimal shift from its calculated mass, consistent with the observed ~67 kDa band. Multi-pass membrane transporters can still smear slightly if not fully denatured, so use fresh sample and complete reduction to keep the band sharp.
Should I expect isoform-specific bands for SLC5A8?
UniProt lists only one canonical SLC5A8 isoform with no annotated splice variants, so a single band near 67 kDa is expected. Multiple bands are more likely to reflect glycosylation heterogeneity, degradation, or nonspecific antibody binding rather than true isoforms.
Does SLC5A8 expression change with treatment or disease?
SLC5A8 is annotated as a tumor suppressor frequently silenced by promoter hypermethylation in epithelial cancers, so expect reduced or absent signal in tumor-derived lines compared to normal colonic or thyroid epithelium. Confirm any loss of signal isn't a technical artifact by including a matched normal-tissue positive control.
How should I optimize blocking for SLC5A8 detection?
As a glycosylated multi-pass membrane protein, SLC5A8 can show elevated background from carbohydrate cross-reactivity; use protein-based blockers such as BSA rather than glycoprotein-rich milk to minimize interference from its single N-glycosylation site, and extend blocking time given its low abundance at the apical membrane.
What transfer method to use for SLC5A8 Western blot?
SLC5A8 is a 66.6 kDa multi-pass membrane transporter, so use wet transfer with 20% methanol and an extended transfer time to ensure efficient elution of this hydrophobic protein from the gel. Semi-dry transfer is more prone to incomplete transfer of large, highly hydrophobic membrane proteins like SLC5A8.
What controls best normalize SLC5A8 quantitation?
Because SLC5A8 localizes specifically to the apical membrane of thyrocytes and colonic epithelial cells, use a membrane-fraction loading control such as Na+/K+-ATPase rather than a generic cytosolic housekeeping protein, and match tissue or cell type between samples to account for its restricted expression pattern.
What could cause extra bands on an SLC5A8 blot?
A higher-molecular-weight band may reflect incomplete denaturation of this multi-pass membrane protein or a retained PDZK1 complex if lysis conditions are too mild; a lower band may indicate proteolytic degradation. Since only one glycosylation site and no disulfide bonds are annotated, extensive laddering is unlikely and more likely reflects nonspecific antibody binding.
Boster reagents

Best SLC5A8 Western Blot Antibodies

BosterBio's SLC5A8 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.

Real WB data Western blot analysis of SLC5A8 using anti-SLC5A8 antibody (A03883-3). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: mouse kidney tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-SLC5A8 antigen affinity purified polyclonal antibody (Catalog # A03883-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for SLC5A8 at approximately 67 kDa. The expected band size for SLC5A8 is at 67 kDa.
Anti-SLC5A8 Antibody Picoband®
Cat # A03883-3

This anti-SLC5A8 antibody is our top-performing, extensively cited, thoroughly validated Western blot reagent, cross-confirmed through negative-tissue controls and complementary methods, giving researchers a dependable, high-confidence choice for specific, reproducible SLC5A8 detection.

Which to pick: Only one Boster anti-SLC5A8 antibody is listed here, A03883-3, which includes an actual Western blot validation image, making it the clear, evidence-backed pick for your SLC5A8 Western blot experiments.

Source: BosterBio SLC5A8 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.

References

  1. UniProt Consortium. UniProt entry Q8N695.
  2. Human Protein Atlas. SLC5A8 tissue expression.